Directors' Shareholdings

RNS Number : 1361X

Advanced Medical Solutions Grp PLC

04 May 2016

 

4 May 2016

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Directors' Shareholdings

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that the Trust which manages the Deferred Share Bonus Plan on behalf of the employees of AMS has purchased ordinary shares of 5 pence each ("Ordinary Shares") on 3 May 2016, at a price of 183 pence per share on behalf of Chris Meredith and Mary Tavener as part of the Deferred Share Bonus Plan and, under the terms of the Plan, these shares will be held in trust on their behalf.

Following these transactions the beneficial ownership of Chris Meredith and Mary Tavener is as follows:

Director	Date purchased	Shares purchased	Resultant holding	% of issued share capital
Chris Meredith Chief Executive Officer	3 May 2016	2,431	1,190,322	0.6
Mary Tavener Chief Financial Officer	3 May 2016	2,431	1,828,129	0.9

-     Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Gary Clarence / Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 510 employees.  For more information please see www.admedsol.com.

 

END

 

 

DSHLLFIDEIIVIIR